Eco Animal Health

Eco Animal Health, a pharmaceutical preparation manufacturer based in Great Britain, has reported its carbon emissions for recent years. In 2022, the company's total Scope 1 and Scope 2 emissions amounted to approximately 20,000 kg CO2e (20 tonnes CO2e). This figure is comprised of about 11,000 kg CO2e (11 tonnes CO2e) from Scope 1 emissions and roughly 9,000 kg CO2e (9 tonnes CO2e) from Scope 2 emissions, with purchased electricity accounting for 8,500 kg CO2e (8.5 tonnes CO2e) of Scope 2.

For the preceding year, 2021, Eco Animal Health's total Scope 1 and Scope 2 emissions were also approximately 20,000 kg CO2e (20 tonnes CO2e). This included around 9,000 kg CO2e (9 tonnes CO2e) from Scope 1 and approximately 11,000 kg CO2e (11 tonnes CO2e) from Scope 2.

The company's emissions data for these years, particularly Scope 1 and 2, does not include Scope 3 emissions. Eco Animal Health's disclosed scopes are 1 and 2, with missing data points noted for Scope 3 categories such as purchased goods and services. The company's performance data originates from ECO Animal Health Ltd.

Eco Animal Health Group plc is identified as a current subsidiary with cascaded data, with ECO Animal Health Ltd. serving as the source organisation for performance. Additionally, CDP reporting originates from ECO Animal Health Group plc at cascade level 1.

While specific reduction targets and commitments are not detailed in the provided information, Eco Animal Health's reporting practices indicate an awareness of its environmental footprint. The company's industry context within Pharmaceutical Preparation Manufacturing suggests a sector increasingly focused on sustainable practices and emission reductions.